---
title: Contemporary Approach to The Diagnosis and Classification of Myelodysplastic
  Neoplasms/Syndromes- Recommendations from The International Consortium for MDS (icMDS)
date: '2024-09-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39322118/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240926193914&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: Myelodysplastic neoplasms/syndromes (MDS) are a heterogeneous group of
  biologically distinct entities characterized by variable degrees of ineffective
  hematopoiesis. Recently, two classification systems (the 5th edition of the WHO
  Classification and the International Consensus Classification) further sub-characterized
  MDS into morphologic and genetically defined groups. Accurate diagnosis and subclassification
  of MDS require a multistep systemic approach. The International Consortium for ...
disable_comments: true
---
Myelodysplastic neoplasms/syndromes (MDS) are a heterogeneous group of biologically distinct entities characterized by variable degrees of ineffective hematopoiesis. Recently, two classification systems (the 5th edition of the WHO Classification and the International Consensus Classification) further sub-characterized MDS into morphologic and genetically defined groups. Accurate diagnosis and subclassification of MDS require a multistep systemic approach. The International Consortium for ...